Evidence map›Paper›PMID 30151372›Full record

ArticleBioMed research international2018

Ouabain Does Not Induce Selective Spiral Ganglion Cell Degeneration in Guinea Pigs.

Timo Schomann, Dyan Ramekers, John C M J de Groot, Carola H van der Ploeg, Ferry G J Hendriksen, Stefan Böhringer, Sjaak F L Klis, Johan H M Frijns, Margriet A Huisman

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Timo SchomannDepartment of Otorhinolaryngology and Head & Neck Surgery, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
Dyan RamekersDepartment of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, 3508 GA Utrecht, Netherlands.
John C M J de GrootDepartment of Otorhinolaryngology and Head & Neck Surgery, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
Carola H van der PloegDepartment of Otorhinolaryngology and Head & Neck Surgery, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
Ferry G J HendriksenDepartment of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, 3508 GA Utrecht, Netherlands.
Stefan BöhringerDepartment of Medical Statistics and Bioinformatics, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
Sjaak F L KlisDepartment of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, 3508 GA Utrecht, Netherlands.
Johan H M FrijnsDepartment of Otorhinolaryngology and Head & Neck Surgery, Leiden University Medical Center, 2300 RC Leiden, Netherlands.ORCID 0000-0002-1180-3314
Margriet A HuismanDepartment of Otorhinolaryngology and Head & Neck Surgery, Leiden University Medical Center, 2300 RC Leiden, Netherlands.ORCID 0000-0001-8704-2999
Leiden University Medical Center · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Round window membrane (RWM) application of ouabain is known to selectively destroy type I spiral ganglion cells (SGCs) in cochleas of several rodent species, while leaving hair cells intact. This protocol has been used in rats and Mongolian gerbils, but observations in the guinea pig are conflicting. This is why we reinvestigated the effect of ouabain on the guinea pig cochlea. Ouabain solutions of different concentrations were placed, in a piece of gelfoam, upon the RWM of the right cochleas. Auditory function was assessed using acoustically evoked auditory brainstem responses (aABR). Finally, cochleas were fixed and processed for histological examination. Due to variability within treatment groups, histological data was pooled and three categories based upon general histological observations were defined: cochleas without outer hair cell (OHC) and SGC loss (Category 1), cochleas with OHC loss only (Category 2), and cochleas with OHC and SGC loss (Category 3). Animals treated with 1 mM or 10 mM ouabain showed shifts in hearing thresholds, corresponding with varying histological changes in their cochleas. Most cochleas exhibited complete outer hair cell loss in the basal and middle turns, while some had no changes, together with either moderate or near-complete loss of SGCs. Neither loss of inner hair cells nor histological changes of the stria vascularis were observed in any of the animals. Cochleas in Category 1 had normal aABRs and morphology. On average, in Category 2 OHC loss was 46.0±5.7%, SGC loss was below threshold, ABR threshold shift was 44.9±2.7 dB, and ABR wave II amplitude was decreased by 17.1±3.8 dB. In Category 3 OHC loss was 68.3±6.9%, SGC loss was 49.4±4.3%, ABR threshold shift was 39.0±2.4 dB, and ABR amplitude was decreased by 15.8±1.6 dB. Our results show that ouabain does not solely destroy type I SGCs in the guinea pig cochlea.

Indexed as

AnimalsAuditory ThresholdCochleaEnzyme InhibitorsEvoked Potentials, Auditory, Brain StemFemaleGuinea PigsHair Cells, Auditory, OuterMaleOuabainSpiral GanglionEnzyme InhibitorsOuabain

Identifiers

PMID30151372
PMCPMC6091334
OpenAlexW2887053785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.